{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:11:58Z","timestamp":1794651118779,"version":"4.9.1"},"reference-count":6,"publisher":"National Center for Global Health and Medicine (JST)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["GHM"],"published-print":{"date-parts":[[2025,4,30]]},"DOI":"10.35772\/ghm.2025.01017","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T22:07:12Z","timestamp":1745878032000},"page":"180-184","source":"Crossref","is-referenced-by-count":3,"title":["Key success factors in clinical trial operation of the smallpox vaccine LC16m8 against mpox in Colombia"],"prefix":"10.35772","volume":"7","author":[{"given":"Naoki","family":"Tomotsugu","sequence":"first","affiliation":[{"name":"Japan Institute for Health Security, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Amaya-Mahecha","sequence":"additional","affiliation":[{"name":"Universidad Nacional de Colombia, Bogot\u00e1, Colombia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieko","family":"Hamana","sequence":"additional","affiliation":[{"name":"Japan Institute for Health Security, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Del Mar","family":"Bautista-Gonzalez","sequence":"additional","affiliation":[{"name":"Universidad Nacional de Colombia, Bogot\u00e1, Colombia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernando Guillermo","family":"Gait\u00e1n-Duarte","sequence":"additional","affiliation":[{"name":"Universidad Nacional de Colombia, Bogot\u00e1, Colombia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Alberto","family":"Cort\u00e9s","sequence":"additional","affiliation":[{"name":"Universidad Nacional de Colombia, Bogot\u00e1, Colombia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohtaro","family":"Mine","sequence":"additional","affiliation":[{"name":"Japan Institute for Health Security, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ainai","sequence":"additional","affiliation":[{"name":"Japan Institute for Health Security, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime E.","family":"Castellanos","sequence":"additional","affiliation":[{"name":"Universidad Nacional de Colombia, Bogot\u00e1, Colombia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Tokita","sequence":"additional","affiliation":[{"name":"Japan Institute for Health Security, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Sugiura","sequence":"additional","affiliation":[{"name":"Japan Institute for Health Security, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mugen","family":"Ujiie","sequence":"additional","affiliation":[{"name":"Japan Institute for Health Security, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Arturo","family":"\u00c1lvarez-Moreno","sequence":"additional","affiliation":[{"name":"Universidad Nacional de Colombia, Bogot\u00e1, Colombia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21485","reference":[{"key":"1","unstructured":"1. World Health Organization. WHO Director-General declares the ongoing monkeypox outbreak a Public Health Emergency of International Concern. <i>https:\/\/www.who.int\/europe\/news-room\/23-07-2022-who-director-general-declares-the-ongoing-monkeypox-outbreak-a-public-health-event-of-international-concern<\/i> (accessed February 27, 2025)."},{"key":"2","unstructured":"2. World Health Organization. WHO Director-General declares mpox outbreak a public health emergency of international concern. <i>https:\/\/www.who.int\/news\/item\/14-8-2024-who-director-general-declares-mpox-outbreak-a-public-health-emergency-of-international-concern<\/i> (accessed February 27, 2025)."},{"key":"3","unstructured":"3. G7, 100 DAYS MISSION to respond to future pandemic threats. <i>https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/992762\/100_Days_Mission_to_respond_to_future_pandemic_threats__3_.pdf<\/i> (accessed February 27, 2025)."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bok K, Sitar S, Graham BS, Mascola JR. Accelerated COVID-19 vaccine development: milestones, lessons, and prospects. Immunity. 2021; 54:1636-1651.","DOI":"10.1016\/j.immuni.2021.07.017"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Burgess LH, Braithwaite JJ, Singleton E, Young AM, Cooper MK. Covid-19: Race for a vaccine. HCA Healthc J Med. 2020; 1:463-474.","DOI":"10.36518\/2689-0216.1228"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Corey L, Miner MD. Accelerating clinical trial development in vaccinology: COVID-19 and beyond. Curr Opin Immunol. 2022; 76:102206.","DOI":"10.1016\/j.coi.2022.102206"}],"container-title":["Global Health &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ghm\/7\/2\/7_2025.01017\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T04:41:41Z","timestamp":1746852101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ghm\/7\/2\/7_2025.01017\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":6,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.35772\/ghm.2025.01017","relation":{},"ISSN":["2434-9186","2434-9194"],"issn-type":[{"value":"2434-9186","type":"print"},{"value":"2434-9194","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"article-number":"2025.01017"}}